Dimer Health Secures $13.5 Million Series A to Scale AI-Driven Post-Discharge Care Model

New updates have been reported about Dimer Health.

Dimer Health has raised $13.5 million in Series A funding to accelerate the national rollout of its clinician-led, AI-native transitional care platform focused on the 30 days after hospital discharge. The round, led by Team8 and Bill Ackman’s Table Management with participation from existing investors Silver Circle and TechAviv, lifts the company’s total funding to nearly $20 million and will support expansion of its post-discharge clinical service line, which is already active across eight states.

Positioned as a dedicated transitional care layer for health systems and payors, Dimer Health uses its proprietary clinical AI system, AiME, to monitor patients at home in real time, interpret symptoms within the context of individual medical histories, and escalate to a licensed “Transitionist” when intervention is needed. This model has delivered up to a 67% reduction in preventable readmissions, sustained a Net Promoter Score above 90, and supported four consecutive quarters of roughly 30% revenue growth, with early adoption spanning 28 facilities and a leading regional payor.

Founded in 2023 and headquartered in Florham Park, New Jersey, Dimer Health was created to address the high-risk, under-served period immediately following hospital discharge, a window that contributes to an estimated $52–62 billion in annual readmission costs in the U.S. healthcare system. CEO and Co-Founder Caroline Hodge, a veteran of DocGo and Envision Healthcare and a former emergency medicine clinician, positions the company’s Transitionist role as a new specialty akin to the emergence of hospitalists, arguing that structured, accountable oversight during recovery at home is the next frontier in care delivery.

Investors view Dimer Health as building critical infrastructure for value-based, post-acute care, citing the company’s early performance as evidence that its AI-enabled, physician-directed model can scale while improving outcomes when patients are most vulnerable. The new capital will be deployed to deepen partnerships with health systems and payors, enhance AiME’s predictive analytics and workflow automation, and modernize legacy discharge processes into a more connected, patient-centric experience, with the goal of embedding Dimer’s service line as a standard component of transitional care nationwide.